MYC and B-cell non-Hodgkin lymphoma: Based on the annotation from UCSC Genome Browser (Karolchik et al. 2014), both of them showed DNase I hypersensitivity and might be targeted binding sites for NRSF, NFKB, and c-Myc. Interestingly, c-Myc was mentioned to participate in recurrent oncogenic translocations in B cell lymphomas (Chiarle et al. 2011).